Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has disclosed a change in director Bruce Gregory Robinson’s indirect interest in the company’s shares. Robinson, through his self-managed superannuation structure Brak Super Pty Ltd as trustee for the Brak Superfund, has increased his holding via an on-market purchase.
On 19 February 2026, Robinson acquired 253 fully paid ordinary Cochlear shares at $198.22 per share, lifting his indirect holding from 1,185 to 1,438 shares. The transaction signals additional personal financial commitment by a board member but does not involve any change to contractual interests or broader capital management activities disclosed in this notice.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$295.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a global medical device company specializing in implantable hearing solutions. Its primary products include cochlear implants and related technologies that restore hearing for people with severe to profound hearing loss across international markets.
Average Trading Volume: 134,626
Technical Sentiment Signal: Sell
Current Market Cap: A$12.62B
See more insights into COH stock on TipRanks’ Stock Analysis page.